As per the news…Glenmark Pharma (parent company) is expecting IPO price of 720 per share for stake sale
| Subscribe To Our Free Newsletter |
Glenmark Life Sciences
As per the news…Glenmark Pharma (parent company) is expecting IPO price of 720 per share for stake sale
